Literature DB >> 20550523

MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.

Guolin Chai1, Ning Liu, Junrong Ma, Hua Li, Janet L Oblinger, Agasanur K Prahalad, Meng Gong, Long-Sheng Chang, Margaret Wallace, David Muir, Abhijit Guha, Roger J Phipps, Janet M Hock, Xijie Yu.   

Abstract

MicroRNAs (miRNAs) are frequently deregulated in human tumors, and play important roles in tumor development and progression. The pathological roles of miRNAs in neurofibromatosis type 1 (NF1) tumorigenesis are largely unknown. We demonstrated that miR-10b was up-regulated in primary Schwann cells isolated from NF1 neurofibromas and in cell lines and tumor tissues from malignant peripheral nerve sheath tumors (MPNSTs). Intriguingly, a significantly high level of miR-10b correlated with low neurofibromin expression was found in a neuroectodermal cell line: Ewing's sarcoma SK-ES-1 cells. Antisense inhibiting miR-10b in NF1 MPNST cells reduced cell proliferation, migration and invasion. Furthermore, we showed that NF1 mRNA was the target for miR-10b. Overexpression of miR-10b in 293T cells suppressed neurofibromin expression and activated RAS signaling. Antisense inhibition of miR-10b restored neurofibromin expression in SK-ES-1 cells, and decreased RAS signaling independent of neurofibromin in NF1 MPNST cells. These results suggest that miR-10b may play an important role in NF1 tumorigenesis through targeting neurofibromin and RAS signaling.
© 2010 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550523     DOI: 10.1111/j.1349-7006.2010.01616.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  46 in total

1.  Relevance of MPNST cell lines as models for NF1 associated-tumors.

Authors:  Eric Pasmant; Armelle Luscan; Jennifer Varin; Ingrid Laurendeau; Béatrice Parfait; Dominique Vidaud
Journal:  J Neurooncol       Date:  2013-06-27       Impact factor: 4.130

2.  Human glioma growth is controlled by microRNA-10b.

Authors:  Galina Gabriely; Ming Yi; Ravi S Narayan; Johanna M Niers; Thomas Wurdinger; Jaime Imitola; Keith L Ligon; Santosh Kesari; Christine Esau; Robert M Stephens; Bakhos A Tannous; Anna M Krichevsky
Journal:  Cancer Res       Date:  2011-04-06       Impact factor: 12.701

Review 3.  The miR-10 microRNA precursor family.

Authors:  Disa Tehler; Nina Molin Høyland-Kroghsbo; Anders H Lund
Journal:  RNA Biol       Date:  2011-09-01       Impact factor: 4.652

4.  NFKB1-miR-612-FAIM2 pathway regulates tumorigenesis in neurofibromatosis type 1.

Authors:  Meng Wang; Zengtao Wang; Xiaolei Zhu; Shibing Guan; Zhibo Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-06-13       Impact factor: 2.416

5.  Heparin impairs angiogenesis through inhibition of microRNA-10b.

Authors:  Xiaokun Shen; Jianping Fang; Xiaofen Lv; Zhicao Pei; Ying Wang; Songshan Jiang; Kan Ding
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

Review 6.  MicroRNAs and metastasis: small RNAs play big roles.

Authors:  Jongchan Kim; Fan Yao; Zhenna Xiao; Yutong Sun; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

Review 7.  Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Authors:  Sebastian Laycock-van Spyk; Nick Thomas; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

8.  Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.

Authors:  Jongchan Kim; Ashley N Siverly; Dahu Chen; Min Wang; Yuan Yuan; Yumeng Wang; Hyemin Lee; Jinsong Zhang; William J Muller; Han Liang; Boyi Gan; Xianbin Yang; Yutong Sun; M James You; Li Ma
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

9.  Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis.

Authors:  Yuxiong Weng; Yanhua Chen; Jianghai Chen; Yutian Liu; Tengfei Bao
Journal:  Med Oncol       Date:  2013-03-13       Impact factor: 3.064

10.  CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.

Authors:  Zhen Yu; Dong Li; Xiu-li Ju
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.